Cargando…

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

The Oncotype DX(®) recurrence score (RS) predictor has been clinically utilized to appropriately select adjuvant chemotherapy for patients with estrogen receptor (ER)-positive early breast cancer. However, the selection of chemotherapy for patients with intermediate RSs remains controversial. We ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Sung Gwe, Lee, Hak Min, Lee, Hak Woo, Lee, Seung Ah, Lee, Se-Ra, Leem, Sun-Hee, Jeong, Joon, Chu, In-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876071/ https://www.ncbi.nlm.nih.gov/pubmed/24304542 http://dx.doi.org/10.3390/ijms141223685

Ejemplares similares

Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2017)

Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay
por: Ahn, Sung Gwe, et al.
Publicado: (2017)

Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2018)

Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor–Positive, ERBB2–Negative Breast Cancer
por: Lee, Janghee, et al.
Publicado: (2022)

Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer
por: Ji, Jung Hwan, et al.
Publicado: (2022)

The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

[18F]-Fluorodeoxyglucose Positron Emission Tomography Can Contribute to Discriminate Patients with Poor Prognosis in Hormone Receptor-Positive Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Long-Term Survival Analysis of Korean Breast Cancer Patients at a Single Center: Improving Outcome Over Time
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Prospective Evaluation of the Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Negative Axillary Conversion after Neoadjuvant Chemotherapy
por: Lee, Hy-De, et al.
Publicado: (2015)

Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

The 70-Gene Prognostic Signature for Korean Breast Cancer Patients
por: Na, Kuk Young, et al.
Publicado: (2011)

Risk Factors for a False-Negative Result of Sentinel Node Biopsy in Patients with Clinically Node-Negative Breast Cancer
por: Lee, Seung Ah, et al.
Publicado: (2018)

Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer
por: Lee, Janghee, et al.
Publicado: (2023)

Comparison of patients with small (≤2 cm) breast cancer according to adherence to breast screening program
por: Park, Jung Min, et al.
Publicado: (2017)

YAP1 Expression in HR+HER2− Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation
por: Park, Inho, et al.
Publicado: (2023)

Prognostic Factors for Patients with Bone-Only Metastasis in Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Clinical Outcomes of Ductal Carcinoma In Situ of the Breast Treated with Partial Mastectomy without Adjuvant Radiotherapy
por: Hwang, Seung Hyun, et al.
Publicado: (2012)

Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse
por: Kim, Hee Jun, et al.
Publicado: (2015)

Genomic Signature of the Standardized Uptake Value in (18)F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2020)

Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk
por: Bae, Soong June, et al.
Publicado: (2021)

Local Control of Brain Metastasis: Treatment Outcome of Focal Brain Treatments in Relation to Subtypes
por: Chong, Jae Uk, et al.
Publicado: (2015)

Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
por: Oh, Jong Jin, et al.
Publicado: (2021)

Patterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients
por: Kim, Hyung Won, et al.
Publicado: (2014)

Standardized uptake value of (18)F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Ex Vivo Shear-Wave Elastography of Axillary Lymph Nodes to Predict Nodal Metastasis in Patients with Primary Breast Cancer
por: Bae, Soong June, et al.
Publicado: (2018)

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease
por: Zerdes, Ioannis, et al.
Publicado: (2020)

Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature
por: Johansson, Annelie, et al.
Publicado: (2022)

Role of Coronary Artery Calcium Scoring in Detection of Coronary Artery Disease according to Framingham Risk Score in Populations with Low to Intermediate Risks
por: Kim, Won-Jang, et al.
Publicado: (2016)

A nomogram constructed using intraoperative ex vivo shear-wave elastography precisely predicts metastasis of sentinel lymph nodes in breast cancer
por: Bae, Soong June, et al.
Publicado: (2019)

Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer
por: Bae, Soong June, et al.
Publicado: (2019)

Gene expression signature of estrogen receptor α status in breast cancer
por: Abba, Martín C, et al.
Publicado: (2005)

Short rare hTERT-VNTR2-2(nd )alleles are associated with prostate cancer susceptibility and influence gene expression
por: Yoon, Se-Lyun, et al.
Publicado: (2010)

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
por: Soliman, Hatem, et al.
Publicado: (2020)

Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer
por: Chae, Eun Young, et al.
Publicado: (2016)

Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial
por: Cho, A-Ra, et al.
Publicado: (2020)

Assessment of vocal fold movement through anterior–posterior view of videofluoroscopic swallowing study
por: Lee, JoonHee, et al.
Publicado: (2023)

Discrimination of Korean ginseng (Panax ginseng Meyer) cultivar Chunpoong and American ginseng (Panax quinquefolius) using the auxin repressed protein gene
por: Kim, Jong-Hak, et al.
Publicado: (2016)

Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
por: Paik, Soonmyung, et al.
Publicado: (2021)

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer
por: Makower, Della, et al.
Publicado: (2021)

Long-term impact of the 70-gene signature on breast cancer outcome
por: Drukker, C. A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8ao81pdj14imqssdnisgs6vi0p